Page last updated: 2024-12-08

4-nitrophenyl beta-cellobioside

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-nitrophenyl beta-cellobioside: RN given refers to (beta)-isomer; see also (alpha)-anomer: 17400-77-0 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID165125
CHEMBL ID350466
MeSH IDM0105496

Synonyms (38)

Synonym
p-nitrophenyl beta-cellobioside
cellobioside, p-nitrophenyl (7ci)
3482-57-3
p-nitrophenyl cellobioside
beta-d-glucopyranoside, 4-nitrophenyl 4-o-beta-d-glucopyranosyl-
para-nitrophenyl beta-d-cellobioside
beta-d-glucopyranoside, 4-nitrophenyl 4-o-beta-d-glucopyranosyl- (9ci)
cellobioside, p-nitrophenyl, beta-d- (8ci)
4-nitrophenyl beta-cellobioside
4-nitrophenyl beta-d-cellobioside
pnpc
p-nitrophenyl beta-d-cellobioside
4-nitrophenyl beta-d-cellobioside, >=98% (tlc)
4-nitrophenyl-beta-d-cellobioside
CHEMBL350466
(2s,3r,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-(4-nitrophenoxy)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
p-nitrophenyl-beta-d-cellobioside
4-nitrophenyl |a-d-cellobioside
AKOS015896873
4-nitrophenyl-beta-d-cellobiopyranoside
mfcd00069845
AS-61338
p-nitrophenyl n-acetyl-beta-d-cellobiopyranoside
IAYJZWFYUSNIPN-KFRZSCGFSA-N
(2s,3r,4s,5s,6r)-2-((2r,3s,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-(4-nitrophenoxy)tetrahydro-2h-pyran-3-yloxy)-6-(hydroxymethyl)tetrahydro-2h-pyran-3,4,5-triol
b-d-glucopyranoside, 4-nitrophenyl4-o-b-d-glucopyranosyl-
4-nitrophenyl beta-d-cellobiopyranoside
A903640
D97694
4-nitrophenyl beta -d-cellobioside
p-nitrophenyl ?-d-cellobioside
HY-137827
CS-0142303
wurcs=2.0/2,2,1/[a2122h-1b_1-5_1*o(c^ec^zc^ec^ec^zc^e$3)/6no/9=o][a2122h-1b_1-5]/1-2/a4-b1
(2s,3r,4s,5s,6r)-2-{[(2r,3s,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-(4-nitrophenoxy)oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
PD063974
AKOS040756238
4-nitrophenyl ??-d-cellobioside
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (8)

Assay IDTitleYearJournalArticle
AID190824Total activity of the entire contents of DSI segment in rat intestine1985Journal of medicinal chemistry, Jan, Volume: 28, Issue:1
Drug glycosides: potential prodrugs for colon-specific drug delivery.
AID190825Total activity of the entire contents of PSI segment in rat intestine1985Journal of medicinal chemistry, Jan, Volume: 28, Issue:1
Drug glycosides: potential prodrugs for colon-specific drug delivery.
AID190826Total activity of the entire contents of cecum segment in rat intestine1985Journal of medicinal chemistry, Jan, Volume: 28, Issue:1
Drug glycosides: potential prodrugs for colon-specific drug delivery.
AID191619Specific activity of the cecum segment in rat intestine1985Journal of medicinal chemistry, Jan, Volume: 28, Issue:1
Drug glycosides: potential prodrugs for colon-specific drug delivery.
AID191617Specific activity of the DSI segment in rat intestine1985Journal of medicinal chemistry, Jan, Volume: 28, Issue:1
Drug glycosides: potential prodrugs for colon-specific drug delivery.
AID191618Specific activity of the PSI segment in rat intestine1985Journal of medicinal chemistry, Jan, Volume: 28, Issue:1
Drug glycosides: potential prodrugs for colon-specific drug delivery.
AID190827Total activity of the entire contents of stomach segment in rat intestine1985Journal of medicinal chemistry, Jan, Volume: 28, Issue:1
Drug glycosides: potential prodrugs for colon-specific drug delivery.
AID191620Specific activity of the stomach segment in rat intestine1985Journal of medicinal chemistry, Jan, Volume: 28, Issue:1
Drug glycosides: potential prodrugs for colon-specific drug delivery.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (31)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (22.58)18.7374
1990's12 (38.71)18.2507
2000's5 (16.13)29.6817
2010's7 (22.58)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.02

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.02 (24.57)
Research Supply Index3.47 (2.92)
Research Growth Index4.49 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.02)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other31 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]